LVESD

AcronymDefinition
LVESDLeft Ventricular End-Systolic Diameters
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Conventional Echocardiographic Findings SSc (n=47) HC (n=20) p LVEDD (cm) 4.95[+ or -]0.22 4.91[+ or -]0.17 0.45 LVESD (cm) 3.09[+ or -]0.2 3.05[+ or -]0.2 0.51 EF (%) 60.1[+ or -]2.18 60.7[+ or -]1.83 0.30 RAD (cm) 3.75[+ or -]0.27 3.49[+ or -]0.34 0.001 RVD (cm) 2.34[+ or -]0.18 2.19[+ or -]0.15 0.002 TAPSE (cm) 2.02[+ or -]0.33 2.96[+ or -]0.51 0.0001 SPAP (mmHg) 30.78[+ or -]4.83 23.35[+ or -]3.23 0.001 TRV (m/sn) 2.62[+ or -]0.31 2.02[+ or -]0.19 0.001 LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; EF: ejection fraction; RAD: right atrial diameter; RVD: right ventricular diameter; TAPSE: tricuspidal annular plane systolic excursion; SPAP: systolic pulmonary artery pressure Table 3.
Deviation LVEDD 41.82 4.83 LVESD 27.28 4.82 IVSD 9.44 1.38 PWD 9.40 1.35 EDV 76.58 22.39 ESV 29.38 13.19 EF 61.74 9.03 FS 33.38 6.00 LV_MASS 90.64 37.18 MAPSE 22.38 4.05 Average Systolic TDI 9.84 1.54 Mean Std.
The average LVEDD and LVESD in SBHF patients were larger than those in CONs (LVEDD: 52.54 [+ or -] 4.71 vs.
Variables Type 2 diabetes (n = 98) Coefficient P value E/A ratio 1.17 [+ or -] 0.04 0.02 0.83 FS (%) 31.6 [+ or -] 2.1 0.10 0.29 EF (%) 63.1 [+ or -] 2.2 0.12 0.25 LVESD (mm) 30.9 [+ or -] 1.3 0.01 0.96 LVEDD (mm) 45.3 [+ or -] 1.9 0.08 0.42 Tei index 0.46 [+ or -] 0.02 0.22 0.03 Circulating cathepsin D levels were log-transformed variable.
The results showed that angiotensin II infusion for 4 weeks induced increases in the LVESD, LVEDD, LVPWD, and IVSD and reductions of the EF and FS.
Ejection fraction, LVEDD, LVESD, and plasma pro-BNP levels of individuals were used to characterize cardiac function.
After 14 weeks of diabetes, LVEDD and LVESD significantly increased in the diabetic group compared with control group.
M-mode echocardiography of DCM associated heart failure dogs revealed significantly increased (P<0.01) LVEdD (61.46 [+ or -] 1.20 mm) and LVEsD (54.14 [+ or -] 1.22 mm) values when compared with mean values of healthy dogs.
Consistent with the heart weight data, no differences in left ventricular end-diastolic dimension (LVEDD), left ventricular endstolic dimension (LVESD), interventricular septal thickness in diastole, and posterior wall thickness in diastole were observed in MyD88 TG mice, suggesting normal anatomy of MyD88 hearts.
ECHO measurements taken before the trial showed cardiac hypertrophy as a sign of long-term chronic effect of exercise, which has also previously been shown to be a typical finding among ultramarathon runners, the left-ventricular end-systolic dimensions (LVEDD and LVESD) serving even as a predictor of faster race times (Nagashima et al., 2006).
Using the M-Mode inte r-ventricular septum and LV posterior wall thickness were measured in systole and diastole as well as left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), EF and shortening fraction (SF).
The following parameters were measured: end-systolic and end-diastolic left ventricle diameters (LVEDd, LVESd), interventricular septum (IVS) and posterior wall (PW) thickness, left atrium (LA) and aorta (Ao) root, starting from the parasternal long-axis view.